Cognitive-behavioural therapy for psychosis

K. Marlowe

South London and Maudsley NHS Trust, Lambeth Early Onset Services, 3–6 Beale House, Lingham Street, London SW9 9HG, UK

EDITED BY STANLEY ZAMMIT

Turkington & McKenna (2003) debate the disingenuous title of whether CBT is worthwhile for psychosis. It is clear that conflict of interest has led to a publication bias with an absence of negative clinical reviews of CBT in the literature. Even so, the current evidence base relies on studies that are based in experimental settings, address a broad spectrum of different diagnoses, and have problems with fidelity to a specific CBT treatment. The most recent meta-analysis (Cormac et al, 2003) finds no convincing change on rating scales at long-term follow up of CBT treatment for schizophrenia, and Pilling et al (2002) suggest that further research is needed to elucidate the therapeutic factors that mediate mental state changes in psychosis. In addition, the most recent published randomised controlled trial of CBT reported no significant differences in clinically significant outcome or even on a unique patient-rated scale (Durham et al, 2003).

The efficacy of these trials with reference to relapse rates or hospital usage is not proven when compared with standard treatment or generic supportive counselling, and the case for the effectiveness and cost-effectiveness of specific psychological treatment teams working with people with psychosis has not been made.

The aim of CBT for psychosis is to develop a collaborative explanation of symptoms and experiences, with a theoretical mechanism of effectiveness to increase control and decrease distress. This aim cannot be accomplished without an aetiological understanding based on hard evidence. The problem of diagnosis of psychosis needs to be addressed since the trials included subjects with a mixture of chronic and acute psychoses, and there was no attempt to assess the duration of untreated illness prior to intervention (independent of whether the index episode was a first or subsequent episode). Worse outcome has been associated with longer duration of untreated psychosis (Johnstone et al, 1992). Rather than abandon CBT for psychosis because of its unproven clinical effectiveness, the way ahead may be to focus on symptom profiles linked to an axis of duration. A theoretical stage-specific CBT model would not exclude the clear biological neurotoxic aetiology of non-affective psychoses, and allows this debate to move on.

REFERENCES

Cormac, I., Jones, C., Campbell C., et al (2003) Cognitive behaviour therapy for schizophrenia. Cochrane Library, issue I. Oxford: Update Software.

Durham, R. C., Guthrie, M., Morton, R. V., et al (2003) Tayside–Fife clinical trial of cognitive–behavioural therapy for medication-resistant psychotic symptoms. Results to 3-month follow-up. British Journal of Psychiatry, 182, 303–311.[Abstract/Free Full Text]

Johnstone, E. C., Frith, C. D., Crow, T. J., et al (1992) The Northwick Park ‘Functional’ Psychosis Study: diagnosis and outcome. Psychological Medicine, 22, 331–346.[Medline]

Pilling, S., Bebbington, P., Kuipers, E., et al (2002) Psychological treatments in schizophrenia: I. Meta-analysis of family intervention and cognitive behaviour therapy. Psychological Medicine, 32, 763–782.[CrossRef][Medline]

Turkington, D. & McKenna, P. (2003) Is cognitive–behavioural therapy a worthwhile treatment for psychosis? British Journal of Psychiatry, 182, 477–479.[Free Full Text]





This Article
Full Text (PDF)
Submit a response
Alert me when this article is cited
Alert me when eLetters are posted
Alert me if a correction is posted
Services
Email this article to a friend
Similar articles in this journal
Similar articles in PubMed
Alert me to new issues of the journal
Download to citation manager
Google Scholar
Articles by Marlowe, K.
Articles citing this Article
PubMed
PubMed Citation
Articles by Marlowe, K.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Psychiatric Bulletin Advances in Psychiatric Treatment All RCPsych Journals